Antistaphylococcal Vaccines and Immunoglobulins

This publication has 57 references indexed in Scilit:

• Phase II, Randomized, Double-Blind, Multicenter Study Comparing the Safety and Pharmacokinetics of Tefibazumab to Placebo for Treatment of Staphylococcus aureus Bacteremia
  Antimicrobial Agents and Chemotherapy, 2006
• Live cell imaging of phagosome maturation in Staphylococcus aureus infected human endothelial cells: small colony variants are able to survive in lysosomes
  Medical Microbiology and Immunology, 2006
• Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections
  Nature Reviews Microbiology, 2006
• Methicillin-ResistantStaphylococcus aureusDisease in Three Communities
  New England Journal of Medicine, 2005
• Staphylococcus aureus types 5 and 8 capsular polysaccharide-protein conjugate vaccines
  American Heart Journal, 2004
• Staphylococcus aureusCapsular Polysaccharides
  Clinical Microbiology Reviews, 2004
• Anti-Clumping Factor A Immunoglobulin Reduces the Duration of Methicillin-ResistantStaphylococcus aureusBacteremia in an Experimental Model of Infective Endocarditis
  Antimicrobial Agents and Chemotherapy, 2003
• Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus
  Proceedings of the National Academy of Sciences, 2002
• Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients
  The Lancet, 2002
• Use of aStaphylococcus aureusConjugate Vaccine in Patients Receiving Hemodialysis
  New England Journal of Medicine, 2002